Drug intelligence / Profile preview

l-glutamine

Development stage
Approved
Lead developer
Cedars-Sinai
Modality
Small Molecules
Administration
Oral
01

Overview

L-glutamine is a naturally occurring amino acid and small molecule being investigated as a metabolic therapeutic in the treatment of advanced pancreatic cancer. In the Phase I GlutaPanc trial led by Dr. Jun Gong at Cedars-Sinai Medical Center, L-glutamine is used as an oral supplement in combination with gemcitabine and nab-paclitaxel. Preclinical evidence suggests that glutamine supplementation can enhance the antitumor activity of gemcitabine against pancreatic ductal adenocarcinoma (PDAC) cells, contrary to the traditional approach of glutamine deprivation. The trial aims to establish the safety and recommended Phase II dose of this combination in treatment-naïve patients with locally advanced or metastatic disease.

Brand names
EndariNutreStore
Other names
levoglutamideL-glutamic acid 5-amideGlutaPanc
02

Targets

Glu (Glutamate)

Beyond the preview

Go deeper on l-glutamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on l-glutamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call